The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy

PURPOSE: This study aims to investigate the predictive value of low skeletal muscle mass (SMM) for cetuximab dose-limiting toxicity (DLT) and its prognostic value in head and neck squamous cell carcinoma (HNSCC) patients treated with concomitant cetuximab and radiotherapy. METHODS: Patients diagnose...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Arch Otorhinolaryngol
Auteurs principaux: Huiskamp, L. F. J., Chargi, N., Devriese, L. A., de Jong, P. A., de Bree, R.
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2020
Sujets:
Head and Neck
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496017/
https://ncbi.nlm.nih.gov/pubmed/32335709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00405-020-05972-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires